1. Generics Bulletin

If Amneal Goes Global Again, It Intends To Go Big

 
• By Aidan Fry

Having just sold off relatively small operations in the UK and Germany, Amneal would look for large-scale deals if it were to expand again beyond its US powerbase. The US generics and specialty brands company is also looking to expand its injectables business and is considering a move into biosimilar insulins.  

Globe
Amneal is not ruling out strategic acquisitions outside of the US, but any deal would have to deliver considerable commercial scale • Source: Shutterstock

US generics supplier Amneal has not ruled out playing in international markets, even though it has just sold off its operations in the UK and Germany. However, any move abroad would have to come through a transaction that immediately gave the firm critical mass, CEO Rob Stewart told investors.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business